FDA Approved: PRASUGREL — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Mylan’s supplemental application for prasugrel, enabling a generic version under ANDA205927.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• PRASUGREL (generic) (prasugrel)

Snippet

SUPPL AP for PRASUGREL (PRASUGREL)